EUVIMEDEUVIMED entdecken
Crossref

Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke

Shanshan Zhang, Ruoqi Li, Meiying Song, Jin Han, Xiang Fan

Journal of Controlled Release · 2025-02 · 378 · 476-489

DOI: 10.1016/j.jconrel.2024.11.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-02. Verfasst von Shanshan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Macrophages, Flavonoids. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The macrophage-derived membrane is widely applied in the targeting nanocarrier for its inflammatory tendency and long circulation ability due to the preservation of membrane protein. Few studies reported the application of macrophage membranes as biotherapeutic agents. To verify the ability of macrophage membrane as a biotherapeutic agent, ischemic stroke was selected as the model disease. Inspired by the features of macrophages infiltrating the ischemic core and the talent of M2 macrophages in modulating the inflammatory microenvironment, an M2 macrophage membrane (M2M)-disguised poly lactic-co-glycolic acid nanoparticles loaded with baicalin (BA) (M2M@BANPs) is developed. The results in vivo and in vitro indicate that M2M@BANPs could efficiently and actively target ischemic brain tissue and accumulate in microglia and neurons due to the coating of M2M. Furthermore, M2M and M2M@BANPs exhibit significant therapeutic effects in salvaging brain tissue damage and neurological functional recovery by reprogramming microglia from M1 to M2, reducing neutrophil infiltration and inhibiting neuronal apoptosis. Together, our fabrication provides a new insight and an applicative perspective for M2M in the therapy of ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeMacrophagesFlavonoidsAnimalsMaleMicePolylactic Acid-Polyglycolic Acid CopolymerNanoparticlesMice, Inbred C57BLMicrogliaRAW 264.7 CellsApoptosisBrain

Stichwörter der Autor:innen

BaicalinBiomimetic nanomedicineIschemic strokeM2 macrophage membrane

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerFlavonoidsbaicalin

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: fanxiang_78@hotmail.com.

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, S., Li, R., Song, M., Han, J., & Fan, X. (2025). Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke. Journal of Controlled Release, 378, 476-489. https://doi.org/10.1016/j.jconrel.2024.11.033

Vancouver

Zhang S, Li R, Song M, Han J, Fan X. Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke. Journal of Controlled Release. 2025;378:476-489. doi:10.1016/j.jconrel.2024.11.033

BibTeX
@article{Zhang2025,
  author = {Zhang, Shanshan and Li, Ruoqi and Song, Meiying and Han, Jin and Fan, Xiang},
  title = {Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {378},
  pages = {476--489},
  doi = {10.1016/j.jconrel.2024.11.033}
}
Kostenlos starten →